Let's Talk Medtech with Dexcom's CEO Kevin Sayer episode artwork

EPISODE · Jun 28, 2021 · 31 MIN

Let's Talk Medtech with Dexcom's CEO Kevin Sayer

from Let’s Talk Medtech

Dexcom's Kevin Sayer discusses the company's studies from ADA, the future of continuous glucose monitoring and gives an update to the G7 device.

Episode metadata supplied by the publisher feed · Published Jun 28, 2021

Embed this episode

Ready to play

Let's Talk Medtech with Dexcom's CEO Kevin Sayer

0:00 31:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Let’s Talk Medtech?

This episode is 31 minutes long.

When was this Let’s Talk Medtech episode published?

This episode was published on June 28, 2021.

Can I download this Let’s Talk Medtech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!